Global Psoriasis Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

July 2018 | 129 pages | ID: GED98F73015EN
GlobalInfoResearch

Abstracts

Psoriasis is a long-lasting autoimmune disease which is characterized by patches of abnormal skin.

Scope of the Report:

This report focuses on the Psoriasis Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Psoriasis Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• AbbVie
• Johnson & Johnson
• Bayer
• Galderma
• Bristol-Myers Squibb
• Novartis
• Pfizer
• Merz Pharma
• Valeant
• LEO Pharma
• GlaxoSmithKline

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• External Use
• Oral
• Injection

Market Segment by Applications, can be divided into

• Hospital
• Drugs Store

There are 15 Chapters to deeply display the global Psoriasis Drug market.
Chapter 1, to describe Psoriasis Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Psoriasis Drug, with sales, revenue, and price of Psoriasis Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Psoriasis Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Psoriasis Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Psoriasis Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Psoriasis Drug Introduction
1.2 Market Analysis by Type
  1.2.1 External Use
  1.2.2 Oral
  1.2.3 Injection
1.3 Market Analysis by Applications
  1.3.1 Hospital
  1.3.2 Drugs Store
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 AbbVie
  2.1.1 Business Overview
  2.1.2 Psoriasis Drug Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 AbbVie Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Johnson & Johnson
  2.2.1 Business Overview
  2.2.2 Psoriasis Drug Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Johnson & Johnson Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bayer
  2.3.1 Business Overview
  2.3.2 Psoriasis Drug Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Bayer Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Galderma
  2.4.1 Business Overview
  2.4.2 Psoriasis Drug Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Galderma Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bristol-Myers Squibb
  2.5.1 Business Overview
  2.5.2 Psoriasis Drug Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Bristol-Myers Squibb Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Novartis
  2.6.1 Business Overview
  2.6.2 Psoriasis Drug Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Novartis Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
  2.7.1 Business Overview
  2.7.2 Psoriasis Drug Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Pfizer Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Merz Pharma
  2.8.1 Business Overview
  2.8.2 Psoriasis Drug Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Merz Pharma Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Valeant
  2.9.1 Business Overview
  2.9.2 Psoriasis Drug Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Valeant Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 LEO Pharma
  2.10.1 Business Overview
  2.10.2 Psoriasis Drug Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 LEO Pharma Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 GlaxoSmithKline
  2.11.1 Business Overview
  2.11.2 Psoriasis Drug Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 GlaxoSmithKline Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL PSORIASIS DRUG SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)

3.1 Global Psoriasis Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Psoriasis Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
  3.3.1 Top 3 Psoriasis Drug Manufacturer Market Share in 2017
  3.3.2 Top 6 Psoriasis Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend

4 GLOBAL PSORIASIS DRUG MARKET ANALYSIS BY REGIONS

4.1 Global Psoriasis Drug Sales, Revenue and Market Share by Regions
  4.1.1 Global Psoriasis Drug Sales and Market Share by Regions (2013-2018)
  4.1.2 Global Psoriasis Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Psoriasis Drug Sales and Growth Rate (2013-2018)
4.3 Europe Psoriasis Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Psoriasis Drug Sales and Growth Rate (2013-2018)
4.5 South America Psoriasis Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Psoriasis Drug Sales and Growth Rate (2013-2018)

5 NORTH AMERICA PSORIASIS DRUG BY COUNTRIES

5.1 North America Psoriasis Drug Sales, Revenue and Market Share by Countries
  5.1.1 North America Psoriasis Drug Sales and Market Share by Countries (2013-2018)
  5.1.2 North America Psoriasis Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Psoriasis Drug Sales and Growth Rate (2013-2018)
5.3 Canada Psoriasis Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Psoriasis Drug Sales and Growth Rate (2013-2018)

6 EUROPE PSORIASIS DRUG BY COUNTRIES

6.1 Europe Psoriasis Drug Sales, Revenue and Market Share by Countries
  6.1.1 Europe Psoriasis Drug Sales and Market Share by Countries (2013-2018)
  6.1.2 Europe Psoriasis Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Psoriasis Drug Sales and Growth Rate (2013-2018)
6.3 UK Psoriasis Drug Sales and Growth Rate (2013-2018)
6.4 France Psoriasis Drug Sales and Growth Rate (2013-2018)
6.5 Russia Psoriasis Drug Sales and Growth Rate (2013-2018)
6.6 Italy Psoriasis Drug Sales and Growth Rate (2013-2018)

7 ASIA-PACIFIC PSORIASIS DRUG BY COUNTRIES

7.1 Asia-Pacific Psoriasis Drug Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Psoriasis Drug Sales and Market Share by Countries (2013-2018)
  7.1.2 Asia-Pacific Psoriasis Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Psoriasis Drug Sales and Growth Rate (2013-2018)
7.3 Japan Psoriasis Drug Sales and Growth Rate (2013-2018)
7.4 Korea Psoriasis Drug Sales and Growth Rate (2013-2018)
7.5 India Psoriasis Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Psoriasis Drug Sales and Growth Rate (2013-2018)

8 SOUTH AMERICA PSORIASIS DRUG BY COUNTRIES

8.1 South America Psoriasis Drug Sales, Revenue and Market Share by Countries
  8.1.1 South America Psoriasis Drug Sales and Market Share by Countries (2013-2018)
  8.1.2 South America Psoriasis Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Psoriasis Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Psoriasis Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Psoriasis Drug Sales and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA PSORIASIS DRUG BY COUNTRIES

9.1 Middle East and Africa Psoriasis Drug Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Psoriasis Drug Sales and Market Share by Countries (2013-2018)
  9.1.2 Middle East and Africa Psoriasis Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Psoriasis Drug Sales and Growth Rate (2013-2018)
9.3 UAE Psoriasis Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Psoriasis Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Psoriasis Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Psoriasis Drug Sales and Growth Rate (2013-2018)

10 GLOBAL PSORIASIS DRUG MARKET SEGMENT BY TYPE

10.1 Global Psoriasis Drug Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Psoriasis Drug Sales and Market Share by Type (2013-2018)
  10.1.2 Global Psoriasis Drug Revenue and Market Share by Type (2013-2018)
10.2 External Use Sales Growth and Price
  10.2.1 Global External Use Sales Growth (2013-2018)
  10.2.2 Global External Use Price (2013-2018)
10.3 Oral Sales Growth and Price
  10.3.1 Global Oral Sales Growth (2013-2018)
  10.3.2 Global Oral Price (2013-2018)
10.4 Injection Sales Growth and Price
  10.4.1 Global Injection Sales Growth (2013-2018)
  10.4.2 Global Injection Price (2013-2018)

11 GLOBAL PSORIASIS DRUG MARKET SEGMENT BY APPLICATION

11.1 Global Psoriasis Drug Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Drugs Store Sales Growth (2013-2018)

12 PSORIASIS DRUG MARKET FORECAST (2018-2023)

12.1 Global Psoriasis Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Psoriasis Drug Market Forecast by Regions (2018-2023)
  12.2.1 North America Psoriasis Drug Market Forecast (2018-2023)
  12.2.2 Europe Psoriasis Drug Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Psoriasis Drug Market Forecast (2018-2023)
  12.2.4 South America Psoriasis Drug Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Psoriasis Drug Market Forecast (2018-2023)
12.3 Psoriasis Drug Market Forecast by Type (2018-2023)
  12.3.1 Global Psoriasis Drug Sales Forecast by Type (2018-2023)
  12.3.2 Global Psoriasis Drug Market Share Forecast by Type (2018-2023)
12.4 Psoriasis Drug Market Forecast by Application (2018-2023)
  12.4.1 Global Psoriasis Drug Sales Forecast by Application (2018-2023)
  12.4.2 Global Psoriasis Drug Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Psoriasis Drug Picture
Table Product Specifications of Psoriasis Drug
Figure Global Sales Market Share of Psoriasis Drug by Types in 2017
Table Psoriasis Drug Types for Major Manufacturers
Figure External Use Picture
Figure Oral Picture
Figure Injection Picture
Figure Psoriasis Drug Sales Market Share by Applications in 2017
Figure Hospital Picture
Figure Drugs Store Picture
Figure United States Psoriasis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Psoriasis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Psoriasis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Psoriasis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure France Psoriasis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure UK Psoriasis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Psoriasis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Psoriasis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure China Psoriasis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Psoriasis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Psoriasis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure India Psoriasis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Psoriasis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Psoriasis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Psoriasis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Psoriasis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Psoriasis Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Psoriasis Drug Revenue (Value) and Growth Rate (2013-2023)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Psoriasis Drug Type and Applications
Table AbbVie Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Psoriasis Drug Type and Applications
Table Johnson & Johnson Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Psoriasis Drug Type and Applications
Table Bayer Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Galderma Basic Information, Manufacturing Base and Competitors
Table Galderma Psoriasis Drug Type and Applications
Table Galderma Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Psoriasis Drug Type and Applications
Table Bristol-Myers Squibb Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Psoriasis Drug Type and Applications
Table Novartis Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Psoriasis Drug Type and Applications
Table Pfizer Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merz Pharma Basic Information, Manufacturing Base and Competitors
Table Merz Pharma Psoriasis Drug Type and Applications
Table Merz Pharma Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Valeant Basic Information, Manufacturing Base and Competitors
Table Valeant Psoriasis Drug Type and Applications
Table Valeant Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table LEO Pharma Basic Information, Manufacturing Base and Competitors
Table LEO Pharma Psoriasis Drug Type and Applications
Table LEO Pharma Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Psoriasis Drug Type and Applications
Table GlaxoSmithKline Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Psoriasis Drug Sales by Manufacturer (2016-2017)
Figure Global Psoriasis Drug Sales Market Share by Manufacturer in 2016
Figure Global Psoriasis Drug Sales Market Share by Manufacturer in 2017
Table Global Psoriasis Drug Revenue by Manufacturer (2016-2017)
Figure Global Psoriasis Drug Revenue Market Share by Manufacturer in 2016
Figure Global Psoriasis Drug Revenue Market Share by Manufacturer in 2017
Figure Top 3 Psoriasis Drug Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Psoriasis Drug Manufacturer (Revenue) Market Share in 2017
Figure Global Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure Global Psoriasis Drug Revenue and Growth Rate (2013-2018)
Table Global Psoriasis Drug Sales by Regions (2013-2018)
Table Global Psoriasis Drug Sales Market Share by Regions (2013-2018)
Table Global Psoriasis Drug Revenue by Regions (2013-2018)
Figure Global Psoriasis Drug Revenue Market Share by Regions in 2013
Figure Global Psoriasis Drug Revenue Market Share by Regions in 2017
Figure North America Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure Europe Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure South America Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure North America Psoriasis Drug Revenue and Growth Rate (2013-2018)
Table North America Psoriasis Drug Sales by Countries (2013-2018)
Table North America Psoriasis Drug Sales Market Share by Countries (2013-2018)
Figure North America Psoriasis Drug Sales Market Share by Countries in 2013
Figure North America Psoriasis Drug Sales Market Share by Countries in 2017
Table North America Psoriasis Drug Revenue by Countries (2013-2018)
Table North America Psoriasis Drug Revenue Market Share by Countries (2013-2018)
Figure North America Psoriasis Drug Revenue Market Share by Countries in 2013
Figure North America Psoriasis Drug Revenue Market Share by Countries in 2017
Figure United States Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure Canada Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure Mexico Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure Europe Psoriasis Drug Revenue and Growth Rate (2013-2018)
Table Europe Psoriasis Drug Sales by Countries (2013-2018)
Table Europe Psoriasis Drug Sales Market Share by Countries (2013-2018)
Table Europe Psoriasis Drug Revenue by Countries (2013-2018)
Figure Europe Psoriasis Drug Revenue Market Share by Countries in 2016
Figure Europe Psoriasis Drug Revenue Market Share by Countries in 2017
Figure Germany Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure UK Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure France Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure Russia Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure Italy Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Psoriasis Drug Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Psoriasis Drug Sales by Countries (2013-2018)
Table Asia-Pacific Psoriasis Drug Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Psoriasis Drug Sales Market Share by Countries 2017
Table Asia-Pacific Psoriasis Drug Revenue by Countries (2013-2018)
Figure Asia-Pacific Psoriasis Drug Revenue Market Share by Countries 2017
Figure China Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure Japan Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure Korea Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure India Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure Southeast Asia Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure South America Psoriasis Drug Revenue and Growth Rate (2013-2018)
Table South America Psoriasis Drug Sales by Countries (2013-2018)
Table South America Psoriasis Drug Sales Market Share by Countries (2013-2018)
Figure South America Psoriasis Drug Sales Market Share by Countries in 2017
Table South America Psoriasis Drug Revenue by Countries (2013-2018)
Table South America Psoriasis Drug Revenue Market Share by Countries (2013-2018)
Figure South America Psoriasis Drug Revenue Market Share by Countries in 2017
Figure Brazil Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure Argentina Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure Colombia Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Psoriasis Drug Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Psoriasis Drug Sales by Countries (2013-2018)
Table Middle East and Africa Psoriasis Drug Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Psoriasis Drug Sales Market Share by Countries in 2017
Table Middle East and Africa Psoriasis Drug Revenue by Countries (2013-2018)
Table Middle East and Africa Psoriasis Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Psoriasis Drug Revenue Market Share by Countries in 2013
Figure Middle East and Africa Psoriasis Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure UAE Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure Egypt Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure Nigeria Psoriasis Drug Sales and Growth Rate (2013-2018)
Figure South Africa Psoriasis Drug Sales and Growth Rate (2013-2018)
Table Global Psoriasis Drug Sales by Type (2013-2018)
Table Global Psoriasis Drug Sales Share by Type (2013-2018)
Table Global Psoriasis Drug Revenue by Type (2013-2018)
Table Global Psoriasis Drug Revenue Share by Type (2013-2018)
Figure Global External Use Sales Growth (2013-2018)
Figure Global External Use Price (2013-2018)
Figure Global Oral Sales Growth (2013-2018)
Figure Global Oral Price (2013-2018)
Figure Global Injection Sales Growth (2013-2018)
Figure Global Injection Price (2013-2018)
Table Global Psoriasis Drug Sales by Application (2013-2018)
Table Global Psoriasis Drug Sales Share by Application (2013-2018)
Figure Global Drugs Store Sales Growth (2013-2018)
Figure Global Psoriasis Drug Sales, Revenue and Growth Rate (2018-2023)
Table Global Psoriasis Drug Sales Forecast by Regions (2018-2023)
Table Global Psoriasis Drug Market Share Forecast by Regions (2018-2023)
Figure North America Sales Psoriasis Drug Market Forecast (2018-2023)
Figure Europe Sales Psoriasis Drug Market Forecast (2018-2023)
Figure Asia-Pacific Sales Psoriasis Drug Market Forecast (2018-2023)
Figure South America Sales Psoriasis Drug Market Forecast (2018-2023)
Figure Middle East and Africa Sales Psoriasis Drug Market Forecast (2018-2023)
Table Global Psoriasis Drug Sales Forecast by Type (2018-2023)
Table Global Psoriasis Drug Market Share Forecast by Type (2018-2023)
Table Global Psoriasis Drug Sales Forecast by Application (2018-2023)
Table Global Psoriasis Drug Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List